Literature DB >> 16112283

Genetic susceptibility to bladder cancer.

Emanuela Taioli1, Sara Raimondi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16112283     DOI: 10.1016/S0140-6736(05)67115-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  Quantitative assessment of the association between TP53 Arg72Pro polymorphism and bladder cancer risk.

Authors:  Zhi-Hong Liu; Er-Dun Bao
Journal:  Mol Biol Rep       Date:  2012-11-27       Impact factor: 2.316

2.  Investigation of key miRNAs and target genes in bladder cancer using miRNA profiling and bioinformatic tools.

Authors:  Kemal Murat Canturk; Muhsin Ozdemir; Cavit Can; Setenay Öner; Ramazan Emre; Huseyin Aslan; Oguz Cilingir; Evrim Ciftci; Fatih Mehmet Celayir; Ozgur Aldemir; Mustafa Özen; Sevilhan Artan
Journal:  Mol Biol Rep       Date:  2014-09-05       Impact factor: 2.316

3.  The MMP-1, MMP-2, and MMP-9 gene polymorphisms and susceptibility to bladder cancer: a meta-analysis.

Authors:  Yulan Yan; Hongjie Liang; Taijie Li; Meng Li; Ruolin Li; Xue Qin; Shan Li
Journal:  Tumour Biol       Date:  2014-01-05

4.  Identification of key pathways and genes influencing prognosis in bladder urothelial carcinoma.

Authors:  Xin Ning; Yaoliang Deng
Journal:  Onco Targets Ther       Date:  2017-03-20       Impact factor: 4.147

Review 5.  Quantitative assessment of the association between MHTFR C677T (rs1801133, Ala222Val) polymorphism and susceptibility to bladder cancer.

Authors:  Wei Xu; Haifeng Zhang; Fa Wang; Honghui Wang
Journal:  Diagn Pathol       Date:  2013-06-17       Impact factor: 2.644

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.